Newcourt Acquisition Corp
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Oct 20, 2021 |
| CEO | Marc Balkin |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 6 + 6 + 1 |
| IPO Sector | Financial ▶ |
| IPO Geography | EEMEA |
| Target Company | Psyence Biomed Corp |
| Deal Announced | Jan 9, 2023 |
| Deal Size, $M | $111.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jan 18, 2024 |
| Amendment Vote | Jan 22, 2024 |
| Closing Date | Jan 25, 2024 |
Formerly NCAC
PBM
PBMWW
| Price | $0.52 $0.01 |
|---|---|
| Last closing price | $0.56 |
| H/L, today | $0.50 / $0.53 |
| Volume, today | 43,637 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.